A carregar...
Targeting B cells for the treatment of SLE: The beginning of the end or the end of the beginning?
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease for which therapeutic advances in immunosuppressive and support therapy have significantly improved survival over the last 5 decades. Unfortunately, SLE still carries substantially increased rates of mortality and end stage renal di...
Na minha lista:
Publicado no: | Discov Med |
---|---|
Main Authors: | , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4557964/ https://ncbi.nlm.nih.gov/pubmed/21122473 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|